Cargando…
Bioassay Development for Bispecific Antibodies—Challenges and Opportunities
Antibody therapeutics are expanding with promising clinical outcomes, and diverse formats of antibodies are further developed and available for patients of the most challenging disease areas. Bispecific antibodies (BsAbs) have several significant advantages over monospecific antibodies by engaging t...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160952/ https://www.ncbi.nlm.nih.gov/pubmed/34069573 http://dx.doi.org/10.3390/ijms22105350 |